166 related articles for article (PubMed ID: 1499169)
1. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.
Dentico P; Buongiorno R; Volpe A; Carlone A; Carbone M; Manno C; Proscia F; Pastore G; Schiraldi O
Clin Nephrol; 1992 Jul; 38(1):49-52. PubMed ID: 1499169
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
[TBL] [Abstract][Full Text] [Related]
6. Antibody to hepatitis C virus increases with time on hemodialysis.
Hardy NM; Sandroni S; Danielson S; Wilson WJ
Clin Nephrol; 1992 Jul; 38(1):44-8. PubMed ID: 1499168
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
Resić H; Sahović V; Mesić E; Leto E
Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
[TBL] [Abstract][Full Text] [Related]
8. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibody to hepatitis C virus in blood donors, high-risk groups and patients with liver diseases in Hungary. A multicentre study using ABBOTT EIA test and a comparison with an ORTHO ELISA test system.
Pár A; Kántor I; Barcsay E; Hollós I; Mezey I; Brojnás J; Takács M; Héjjas M; Illés M; Szontágh L
Acta Med Hung; 1991; 48(3-4):167-76. PubMed ID: 1726611
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C infection in a pediatric dialysis population.
Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y
Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
Chan TM; Lok AS; Cheng IK; Chan RT
Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
15. [The prevalence of anti-hepatitis virus C antibodies in chronic hemodialysis patients].
Camps DH; Azcona S; Bertola S; Kohn I; Noguera E; Garzón Maceda F; Bongiorno E; Massari P; De Arteaga J
Medicina (B Aires); 1992; 52(6):511-5. PubMed ID: 1340899
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anti-HCV in patients on long-term hemodialysis.
Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
20. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]